Genetic Technologies Limited

GNTLF · OTC
Analyze with AI
6/30/2024
6/30/2023
6/30/2022
6/30/2021
Operating Activities
Net Income-$12,017-$11,751-$7,131-$7,078
Dep. & Amort.$535$677$579$478
Deferred Tax$0-$582$1,803-$444
Stock-Based Comp.$124$253$438$715
Change in WC-$31$328-$2,241-$271
Other Non-Cash$1,710$1,351$893$303
Operating Cash Flow-$9,679-$9,723-$5,659-$6,296
Investing Activities
PP&E Inv.-$33-$18-$97-$642
Net Acquisitions$0-$486-$3,475$0
Inv. Purchases$0$0$0$0
Inv. Sales/Matur.$0$0$0$0
Other Inv. Act.$148$192$111$0
Investing Cash Flow$115-$312-$3,461-$642
Financing Activities
Debt Repay.$252-$336-$269-$237
Stock Issued$2,577$7,172-$10$15,898
Stock Repurch.$0$0$0$0
Dividends Paid$0$0$0$0
Other Fin. Act.-$7-$916$0-$1,971
Financing Cash Flow$2,822$5,920-$279$13,690
Forex Effect-$89$235$229$43
Net Chg. in Cash-$6,831-$3,880-$9,171$6,689
Supplemental Information
Beg. Cash$7,851$11,731-$9,641$14,214
End Cash$1,021$7,851$11,733$20,903
Free Cash Flow-$9,712-$9,741-$5,756-$6,938
Genetic Technologies Limited (GNTLF) Financial Statements & Key Stats | AlphaPilot